Back to News
Market Impact: 0.2
Altruist Biologics' Suzhou Facility Clears EMA GMP Inspection
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Altruist Biologics, Innovent Biologics' wholly owned CDMO subsidiary, announced that its commercial manufacturing facility in Suzhou cleared a Good Manufacturing Practice inspection. The GMP clearance supports the facility's manufacturing compliance and commercial production capabilities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- These funds tout hefty income tied to the tech trade – if you’re willing to deal with the complexity
- Street Calls of The Week
- Florida’s new property tax cuts could defund the police, fire fighters and EMS in small towns, threatening ‘rural dark ages,’ former GOP lawmaker says
- Asia Markets Brace for More AI Volatility
- Meta’s $25 Billion Bond Sale Highlights Shifting Landscape for Tech Debt